TY - JOUR
T1 - Meeting Report: 20 years after the First International Symposium on hepatitis C virus and related viruses
AU - Carnero, Elena
AU - Diez, Juana
AU - Fortes, Purificacion
AU - Gastaminza, Pablo
AU - Majano, Pedro
AU - Angel Martinez, Miguel
AU - Perez-del-Pulgar, Sofia
AU - Quer, Josep
AU - Xavier Lopez-Labrador, F.
PY - 2013/12/1
Y1 - 2013/12/1
N2 - The hepatitis C virus (HCV) was discovered by the team of Michael Houghton at Chiron Corporation in 1989 and the first symposium on HCV and related viruses was held in Venice, Italy, shortly after, in 1992. This conference was organized to advance knowledge on what then was a mysterious virus responsible for most cases of "non-A, non-B" hepatitis. During the 20 years since the first conference, the scientific quality of presentations has steadily increased, together with the tremendous advances in basic and clinical research and epidemiology. What started as a small conference on a new virus, about which there were very few data, has today become a first-in-class congress: a meeting place for basic researchers, clinicians, epidemiologists, public health experts, and industry members to present the most important advances and their application to HCV treatment and control. The nineteenth HCV symposium was held in September 2012, once again in Venice. (C) 2013 Elsevier Espana, S.L. and AEEH y AEG. All rights reserved.
AB - The hepatitis C virus (HCV) was discovered by the team of Michael Houghton at Chiron Corporation in 1989 and the first symposium on HCV and related viruses was held in Venice, Italy, shortly after, in 1992. This conference was organized to advance knowledge on what then was a mysterious virus responsible for most cases of "non-A, non-B" hepatitis. During the 20 years since the first conference, the scientific quality of presentations has steadily increased, together with the tremendous advances in basic and clinical research and epidemiology. What started as a small conference on a new virus, about which there were very few data, has today become a first-in-class congress: a meeting place for basic researchers, clinicians, epidemiologists, public health experts, and industry members to present the most important advances and their application to HCV treatment and control. The nineteenth HCV symposium was held in September 2012, once again in Venice. (C) 2013 Elsevier Espana, S.L. and AEEH y AEG. All rights reserved.
KW - Antivirals
KW - Chronic hepatitis
KW - Epidemiology
KW - Pathogenesis
KW - Vaccine
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=uab_pure&SrcAuth=WosAPI&KeyUT=WOS:000328809800007&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.1016/j.gastrohep.2013.06.001
DO - 10.1016/j.gastrohep.2013.06.001
M3 - Article
C2 - 24011709
SN - 0210-5705
VL - 36
SP - 641
EP - 646
JO - Gastroenterologia y Hepatologia
JF - Gastroenterologia y Hepatologia
IS - 10
ER -
